chartexchange

Atossa Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Corporate Update

PR Newswire | Nov 10, 2026 8:15 AM EST

SEATTLE, Nov. 10, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of high unmet clinical need, today announced its financial results for the third...

Read original article